Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-27 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +9,338 91,582
2024-02-27 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +6,465 98,047
2024-02-27 FUCHS HENRY J President, Worldwide R&D Grant or award +30,640 224,894
2024-02-27 FUCHS HENRY J President, Worldwide R&D Grant or award +13,326 238,220
2024-02-27 FUCHS HENRY J President, Worldwide R&D Grant or award +9,238 247,458
2024-02-27 BIENAIME JEAN JACQUES Director Grant or award +82,700 502,302
2024-02-27 BIENAIME JEAN JACQUES Director Grant or award +35,975 538,277
2024-02-27 BIENAIME JEAN JACQUES Director Grant or award +24,926 563,203
2024-02-27 BIENAIME JEAN JACQUES Director Sale −1,000 $90.35 $90K 562,203
2024-02-09 BIENAIME JEAN JACQUES Director Exercise or conversion 10b5-1 +15,000 $63.10 $947K 434,602
2024-02-09 BIENAIME JEAN JACQUES Director Sale 10b5-1 −15,000 $88.28 $1.3M 419,602
2024-02-09 BIENAIME JEAN JACQUES Director Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −15,000 131,000
2024-02-08 BIENAIME JEAN JACQUES Director Exercise or conversion 10b5-1 +15,000 $63.10 $947K 434,602
2024-02-08 BIENAIME JEAN JACQUES Director Sale 10b5-1 −15,000 $89.77 $1.3M 419,602
2024-02-08 BIENAIME JEAN JACQUES Director Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −15,000 146,000
2024-01-18 BIENAIME JEAN JACQUES Director Other acquisition 10b5-1 +40 $92.60 $4K 419,602
2024-01-10 BIENAIME JEAN JACQUES Director Exercise or conversion 10b5-1 +10,000 $63.10 $631K 435,162
2024-01-10 BIENAIME JEAN JACQUES Director Sale 10b5-1 −10,000 $96.38 $964K 425,162
2024-01-10 BIENAIME JEAN JACQUES Director Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 −10,000 161,000
2024-01-09 BIENAIME JEAN JACQUES Director Exercise or conversion 10b5-1 +10,000 $63.10 $631K 435,162

Page 11 of 23 · 450 trades